InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges
InMode (NASDAQ: INMD) has secured a significant legal victory against counterfeit sellers on DHGate platform. The US District Court for the Central District of California has granted InMode a permanent injunction and damages against defendants selling counterfeit Morpheus8 radio frequency microneedling devices and needle cartridges. The court ruling includes freezing the defendants' assets and halting their product listings.
The decision favors InMode on all claims including trademark infringement, false designation of origin, and California unfair competition. To combat counterfeiting, InMode has launched a Verified Provider Program for Morpheus8, enabling certified clinics to demonstrate their authenticity. Patients can verify authorized providers through InMode's Find a Provider tool at www.inmodemd.com.
InMode (NASDAQ: INMD) ha ottenuto una vittoria legale significativa contro i venditori di prodotti contraffatti sulla piattaforma DHGate. Il Tribunale Distrettuale degli Stati Uniti per il Distretto Centrale della California ha concesso a InMode un provvedimento permanente e risarcimenti contro i responsabili della vendita di dispositivi contraffatti Morpheus8 per microneedling a radiofrequenza e relative cartucce per aghi. La sentenza prevede il blocco dei beni dei convenuti e la sospensione delle loro inserzioni di prodotto.
La decisione è favorevole a InMode su tutte le accuse, inclusa la violazione del marchio, la falsa indicazione di origine e la concorrenza sleale in California. Per contrastare la contraffazione, InMode ha lanciato un Programma di Fornitori Verificati per Morpheus8, che consente alle cliniche certificate di dimostrare la loro autenticità. I pazienti possono verificare i fornitori autorizzati attraverso lo strumento Find a Provider di InMode sul sito www.inmodemd.com.
InMode (NASDAQ: INMD) ha logrado una importante victoria legal contra vendedores de productos falsificados en la plataforma DHGate. El Tribunal de Distrito de los Estados Unidos para el Distrito Central de California otorgó a InMode una orden judicial permanente y daños y perjuicios contra los acusados que vendían dispositivos falsificados Morpheus8 de microneedling por radiofrecuencia y cartuchos de agujas. La sentencia incluye el congelamiento de los activos de los acusados y la suspensión de sus listados de productos.
La decisión favorece a InMode en todas las reclamaciones, incluyendo la infracción de marca registrada, la falsa designación de origen y la competencia desleal en California. Para combatir la falsificación, InMode ha lanzado un Programa de Proveedores Verificados para Morpheus8, que permite a las clínicas certificadas demostrar su autenticidad. Los pacientes pueden verificar a los proveedores autorizados a través de la herramienta Find a Provider de InMode en www.inmodemd.com.
InMode (NASDAQ: INMD)는 DHGate 플랫폼에서 위조 판매자에 대해 중요한 법적 승리를 거두었습니다. 캘리포니아 중부 지방법원은 InMode에 대해 모피어스8 라디오 주파수 마이크로니들링 장치 및 니들 카트리지 위조 판매자들에 대해 영구 금지 명령과 손해 배상을 승인했습니다. 법원 판결에는 피고의 자산 동결 및 제품 목록 중단이 포함되어 있습니다.
이번 결정은 상표권 침해, 원산지 허위 표시, 캘리포니아 불공정 경쟁 등 모든 청구에서 InMode에 유리하게 나왔습니다. 위조 방지를 위해 InMode는 모피어스8 인증 공급자 프로그램을 시작하여 인증된 클리닉이 진품임을 증명할 수 있도록 했습니다. 환자들은 InMode의 Find a Provider 도구(www.inmodemd.com)를 통해 인증된 공급자를 확인할 수 있습니다.
InMode (NASDAQ : INMD) a remporté une victoire juridique importante contre les vendeurs de contrefaçons sur la plateforme DHGate. Le tribunal de district des États-Unis pour le district central de Californie a accordé à InMode une injonction permanente et des dommages-intérêts contre les défendeurs vendant des dispositifs Morpheus8 de microneedling par radiofréquence et des cartouches d'aiguilles contrefaits. Le jugement comprend le gel des actifs des défendeurs et l'arrêt de leurs annonces de produits.
La décision est favorable à InMode sur toutes les revendications, y compris la contrefaçon de marque, la fausse désignation d'origine et la concurrence déloyale en Californie. Pour lutter contre la contrefaçon, InMode a lancé un Programme de Fournisseurs Vérifiés pour Morpheus8, permettant aux cliniques certifiées de prouver leur authenticité. Les patients peuvent vérifier les fournisseurs autorisés via l'outil Find a Provider d'InMode sur www.inmodemd.com.
InMode (NASDAQ: INMD) hat einen bedeutenden rechtlichen Sieg gegen Fälschungsverkäufer auf der DHGate-Plattform errungen. Das US-Bezirksgericht für den zentralen Bezirk von Kalifornien hat InMode eine dauerhafte einstweilige Verfügung und Schadensersatz gegen die Beklagten gewährt, die gefälschte Morpheus8 Radiofrequenz-Microneedling-Geräte und Nadelkartuschen verkaufen. Das Gerichtsurteil umfasst das Einfrieren der Vermögenswerte der Beklagten und die Einstellung ihrer Produktangebote.
Die Entscheidung fällt zugunsten von InMode in allen Ansprüchen, einschließlich Markenrechtsverletzung, falscher Herkunftsbezeichnung und unlauterem Wettbewerb in Kalifornien. Um der Produktfälschung entgegenzuwirken, hat InMode ein Verifiziertes Anbieterprogramm für Morpheus8 gestartet, das zertifizierten Kliniken ermöglicht, ihre Echtheit zu zeigen. Patienten können autorisierte Anbieter über das Find a Provider-Tool von InMode auf www.inmodemd.com überprüfen.
- None.
- Presence of counterfeit products in the market indicates potential revenue loss and brand reputation risks
Insights
Court grants InMode default judgment against counterfeit sellers, with permanent injunction and damages for trademark infringement, protecting brand integrity and patient safety.
The US District Court for the Central District of California has granted InMode a significant legal victory through a default judgment against DHGate sellers of counterfeit Morpheus8 radio frequency microneedling devices. This judgment includes both a permanent injunction preventing further trademark infringement and monetary damages awarded to InMode. Default judgments occur when defendants fail to respond to legal proceedings, effectively conceding the case.
The court ruled in InMode's favor on all three legal claims: trademark infringement, false designation of origin, and California unfair competition. The comprehensive nature of this ruling strengthens InMode's position in protecting its intellectual property rights. Additionally, the court ordered the freezing of the defendants' assets and the removal of their product listings, providing immediate protective action for InMode's trademarks.
This case demonstrates the legal system's recognition of the seriousness of counterfeit medical devices, particularly given the safety concerns associated with unauthorized versions of devices used in aesthetic procedures. InMode's proactive legal strategy shows commitment to defending its MORPHEUS® and INMODE® trademarks, which are crucial business assets in the medical technology sector.
Legal victory protects InMode's brand and revenue while Verified Provider Program strengthens market position and addresses critical counterfeiting issues in medical aesthetics.
InMode's legal victory against counterfeit sellers of its Morpheus8 devices addresses a critical issue in the medical aesthetics industry. Counterfeit medical devices present dual concerns: they undermine legitimate manufacturers' revenue while potentially compromising patient safety due to unverified manufacturing standards. For aesthetic devices like Morpheus8, which involves direct contact with patients' skin and tissue, ensuring authentic equipment is particularly important.
The company's establishment of a Verified Provider Program represents a strategic industry approach to counterfeiting, creating a certification system that helps patients identify authorized clinics using genuine Morpheus8 technology. This program serves multiple business purposes: it helps protect brand integrity, strengthens relationships with legitimate providers, and creates a direct channel for patient verification through InMode's "Find a Provider" tool.
For a public company like InMode, aggressive protection of intellectual property and brand integrity is particularly important in the competitive medical aesthetics market, where product differentiation and trust are key competitive factors. The company's stated "zero-tolerance policy" indicates management's commitment to addressing this issue systematically, which aligns with both consumer safety interests and shareholder value protection.
The Court's decision aims to protect safety and uphold InMode's trademark rights. The injunction includes freezing the assets and halting the listings of the sellers involved in the counterfeit trade. The ruling favors InMode on all claims (trademark infringement, false designation of origin, and
"InMode maintains a zero-tolerance policy towards fraudulent business practices including counterfeit goods and for any platforms or sellers who are using, selling, or distributing false products," says Moshe Mizrahy, CEO of InMode. "We are committed to public safety and will continue to protect consumers from potential harm caused by unauthorized Morpheus8 devices."
InMode has established a Verified Provider Program for Morpheus8, allowing certified clinics to showcase their authenticity and confirm they use genuine Morpheus8 technology. This initiative helps patients identify safe, authorized providers committed to delivering trusted InMode results.
Patients in
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.
Press Contact:
Behrman Cesa Communications
inmode@behrmancesa.com
Investor Contact:
MS-IR LLC
Miri Segal – Scharia
ir@inmodemd.com
Tel: 917-607-8654
Logo - https://mma.prnewswire.com/media/1064477/5298285/InMode_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-granted-injunction-against-counterfeit-sales-of-morpheus8-radio-frequency-microneedling-devices-and-needle-cartridges-302446235.html
SOURCE InMode Ltd.
FAQ
What legal action did InMode (INMD) win against counterfeit sellers?
How can patients verify authentic Morpheus8 providers for InMode treatments?
What claims did InMode win in the counterfeit case?
What measures has InMode implemented to combat counterfeit Morpheus8 devices?
